Enhanced sensitivity for AKT inhibition under hypoxia was observed in part of HNSCC and NSCLC lines, irrespective of the effect of AKT inhibition on hypoxic HIF-1 signaling. This evidence concerns the gene AKT1 and non-small cell lung carcinoma.